Mithridion Lands $1,250,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7f882144-5f7b-4e69-8157-0f79f376b94f&Preview=1 - Date
1/11/2011 - Company Name
Mithridion - Mailing Address
505 Science Drive Madison, WI 537121 - Company Description
Mithridion is a biopharmaceutical company that discovers and develops drugs for neurodegenerative diseases, with a focus on Alzheimer’s disease. - Website
http://www.mithridion.com - Transaction Type
Venture Equity - Transaction Amount
$1,250,000 - Transaction Round
Undisclosed - Proceeds Purposes
Mithridion intends to develop its drug candidates for AD and schizophrenia in partnership with pharmaceutical or biopharmaceutical companies with the technical, manufacturing and commercial resources to address these major market opportunities. - M&A Terms
- Venture Investor
Venture Investors - Venture Investor
Rocket Ventures
